Dupilumab improved lung function and reduces exacerbations in patients with 1, 2, or 3 prior exacerbations: TRAVERSE
J. Corren (Los Angeles, CA, United States), M. Castro (Kansas City, KS, United States), J. Maspero (Buenos Aires, Argentina), M. Humbert (Le Kremlin-Bicêtre, France), D. Halpin (Exeter, United Kingdom), A. Altincatal (Cambridge, MA, United States), N. Pandit-Abid (Bridgewater, NJ, United States), X. Soler (Tarrytown, NY, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridgewater, NJ, United States), Y. Deniz (Tarrytown, NY, United States), P. Rowe (Bridgewater, NJ, United States), J. Maspero (Ciudad Autónoma Buenos Aires, Argentina)
Source: International Congress 2022 – Recent advances in biological treatments for asthma
Session: Recent advances in biological treatments for asthma
Session type: Oral Presentation
Number: 3672
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Corren (Los Angeles, CA, United States), M. Castro (Kansas City, KS, United States), J. Maspero (Buenos Aires, Argentina), M. Humbert (Le Kremlin-Bicêtre, France), D. Halpin (Exeter, United Kingdom), A. Altincatal (Cambridge, MA, United States), N. Pandit-Abid (Bridgewater, NJ, United States), X. Soler (Tarrytown, NY, United States), S. Siddiqui (Tarrytown, NY, United States), J. Jacob-Nara (Bridgewater, NJ, United States), Y. Deniz (Tarrytown, NY, United States), P. Rowe (Bridgewater, NJ, United States), J. Maspero (Ciudad Autónoma Buenos Aires, Argentina). Dupilumab improved lung function and reduces exacerbations in patients with 1, 2, or 3 prior exacerbations: TRAVERSE. 3672
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|